Trials / Completed
CompletedNCT00801814
Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia
Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Glycemic Index Laboratories, Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | PolyGlycopleX (PGX) | 2.5 grams of PGX |
| DIETARY_SUPPLEMENT | PolyGlycopleX (PG) | 5.0 grams of PGX |
| DIETARY_SUPPLEMENT | PolyGlycopleX | 7.5 grams of PGX |
| DIETARY_SUPPLEMENT | Control | 0g of PGX |
| DIETARY_SUPPLEMENT | Second Control | 0g of PGX |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-05-01
- Completion
- 2006-08-01
- First posted
- 2008-12-04
- Last updated
- 2008-12-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00801814. Inclusion in this directory is not an endorsement.